Medicinova (MNOV) Gains from Investment Securities (2021 - 2025)
Medicinova (MNOV) has disclosed Gains from Investment Securities for 7 consecutive years, with -$199.0 as the latest value for Q4 2025.
- On a quarterly basis, Gains from Investment Securities changed N/A to -$199.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $199233.0, a N/A change, with the full-year FY2024 number at $42281.0, down 99.46% from a year prior.
- Gains from Investment Securities was -$199.0 for Q4 2025 at Medicinova, down from $7.9 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $8.6 million in Q1 2024 to a low of -$875801.0 in Q4 2021.
- A 5-year average of $2.1 million and a median of $512000.0 in 2025 define the central range for Gains from Investment Securities.
- Biggest YoY gain for Gains from Investment Securities was 32049.02% in 2024; the steepest drop was 105.34% in 2024.
- Medicinova's Gains from Investment Securities stood at -$875801.0 in 2021, then skyrocketed by 165.96% to $577700.0 in 2022, then surged by 36.52% to $788683.0 in 2023, then tumbled by 105.34% to -$42082.0 in 2024, then soared by 99.53% to -$199.0 in 2025.
- Per Business Quant, the three most recent readings for MNOV's Gains from Investment Securities are -$199.0 (Q4 2025), $7.9 million (Q3 2025), and $512000.0 (Q2 2025).